C-C Chemokine Receptor Type 6 (CCR6) Antibody

Este producto es parte de CCR - C-C chemokine receptor type
Product Graph
169€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
C-C Chemokine Receptor Type 6 (CCR6) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx302634
tested applications
ELISA, WB

Description

CCR6 Antibody is a Rabbit Polyclonal against CCR6.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

CategoryPrimary Antibodies
Immunogen TargetC-C Chemokine Receptor Type 6 (CCR6)
HostRabbit
ReactivityHuman
Recommended DilutionWB: 1/500 - 1/2000. Optimal dilutions/concentrations should be determined by the end user.
ClonalityPolyclonal
ConjugationUnconjugated
IsotypeIgG
Purity> 95%
PurificationPurified by Protein G.
Size 120 µg
Size 250 µg
Size 3100 µg
Size 4200 µg
Size 51 mg
FormLiquid
Tested ApplicationsELISA, WB
Buffer0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol.
AvailabilityShipped within 5-10 working days.
StorageAliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry IceNo
UniProt IDP51684
Gene ID1235
OMIM601835
AliasCCR6,CKR-L3,DCCR2,GPR-CY4,STRL22,DRY-6,GPR29,CD196,BN-1,C-C CKR-6,CC-CKR-6,CCR-6,CKRL3, CMKBR6, DCR2, DRY6, GPR29, GPRCY4, STRL22,C-C motif chemokine receptor 6
BackgroundAntibody anti-CCR6
StatusRUO

Descripción

C-C Chemokine Receptor Type 6 (CCR6) is a G-protein-coupled receptor expressed on subsets of B cells, T-helper 17 (Th17) cells, regulatory T cells (Tregs), dendritic cells, and memory T cells. CCR6 binds its ligand CCL20 (MIP-3α) to regulate immune cell migration to sites of inflammation, infection, and mucosal tissues. It plays a pivotal role in mucosal immunity, promoting the trafficking of lymphocytes and dendritic cells to the gut-associated lymphoid tissue (GALT), where it contributes to host defense and immune homeostasis. CCR6 is essential for Th17 cell recruitment, which is critical for combating extracellular bacteria and fungi but can also drive autoimmune diseases like psoriasis, rheumatoid arthritis, and inflammatory bowel disease (IBD) when dysregulated. CCR6 also facilitates immune tolerance through its expression on Tregs, balancing pro-inflammatory and anti-inflammatory responses. In cancer, CCR6 is associated with tumor progression and metastasis, particularly in colorectal cancer and hepatocellular carcinoma, by mediating immune cell infiltration and fostering a tumor-permissive microenvironment. The CCR6-CCL20 axis has also been implicated in HIV infection, as CCR6+ T cells are preferential targets for viral replication. Targeting CCR6 and its signaling pathways holds therapeutic promise for autoimmune diseases, infectious diseases, and cancer immunotherapy. Ongoing research continues to elucidate its complex roles in immunity, inflammation, and disease pathology.

Related Products

EH2047

Human CCR6(C-C chemokine receptor type 6) ELISA Kit

Ver Producto
EM0710

Mouse Ccr6(C-C chemokine receptor type 6) ELISA Kit

Ver Producto
abx137237

C-C Chemokine Receptor Type 6 (CCR6) Antibody

C-C Chemokine Receptor Type 6 (CCR6) Antibody is a Mouse Monoclonal antibody against C-C Chemokine Receptor Type 6 (CCR6).

Ver Producto